Patent · US Active

Compositions and methods for the treatment of tumor of hematopoietic origin

US8388973B2 · kind B2 · utility

7Cited by

5References

58Claims

0Family size

Assignee

Genentech, Inc. · US

Inventors

Wesley Chang · Redwood City, US
Frederic J. de Sauvage · Foster City, US
Dan Eaton · San Rafael, US
Allen Ebens · Redwood City, US
Gretchen Frantz · San Francisco, US
Jo-Anne Hongo · Redwood City, US
Hartmut Koeppen · San Mateo, US
Andrew Polson · San Francisco, US
Victoria Smith · Burlingame, US

Key dates

Filing date	Dec 30, 2010
Grant date	Mar 5, 2013
Priority date	—
Expiry date	Dec 30, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/505
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.